β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor

The transcription factor Microphthalmia-associated transcription factor (MITF) is a lineage-determination factor, which modulates melanocyte differentiation and pigmentation. MITF was recently shown to reside downstream of the canonical Wnt pathway during melanocyte differentiation from pluripotent neural crest cells in zebrafish as well as in mammalian melanocyte lineage cells. Although expression of many melanocytic/pigmentation markers is lost in human melanoma, MITF expression remains intact, even in unpigmented tumors, suggesting a role for MITF beyond its role in differentiation. A significant fraction of primary human melanomas exhibit deregulation (via aberrant nuclear accumulation) of β-catenin, leading us to examine its role in melanoma growth and survival. Here, we show that β-catenin is a potent mediator of growth for melanoma cells in a manner dependent on its downstream target MITF. Moreover, suppression of melanoma clonogenic growth by disruption of β-catenin–T-cell transcription factor/LEF is rescued by constitutive MITF. This rescue occurs largely through a prosurvival mechanism. Thus, β-catenin regulation of MITF expression represents a tissue-restricted pathway that significantly influences the growth and survival behavior of this notoriously treatment-resistant neoplasm.

[1]  R. Boissy,et al.  A mouse model for vitiligo. , 1986, The Journal of investigative dermatology.

[2]  N. Jenkins,et al.  Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein , 1993, Cell.

[3]  C. Goding,et al.  Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator , 1994, Molecular and cellular biology.

[4]  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene , 1994 .

[5]  James A. Vaught,et al.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. , 1994, Genes & development.

[6]  X. Liu,et al.  A gene for Waardenburg Syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12–p14.1 , 1994, Nature Genetics.

[7]  R. Sears,et al.  The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. , 1994, Genes & development.

[8]  S. Shibahara,et al.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene , 1994, Molecular and cellular biology.

[9]  H Clevers,et al.  Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties , 1996, Molecular and cellular biology.

[10]  K Takahashi,et al.  Functional Analysis of Microphthalmia-associated Transcription Factor in Pigment Cell-specific Transcription of the Human Tyrosinase Family Genes* , 1997, The Journal of Biological Chemistry.

[11]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[12]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[13]  W. Pavan,et al.  Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. , 1997, Development.

[14]  A. McMahon,et al.  Wnt signalling required for expansion of neural crest and CNS progenitors , 1997, Nature.

[15]  E. Price,et al.  α-Melanocyte-stimulating Hormone Signaling Regulates Expression of microphthalmia, a Gene Deficient in Waardenburg Syndrome* , 1998, The Journal of Biological Chemistry.

[16]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[17]  D. Fisher,et al.  Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes , 1998, The Journal of cell biology.

[18]  D. McConkey,et al.  CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells* , 1998, The Journal of Biological Chemistry.

[19]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[20]  Randall T. Moon,et al.  Control of neural crest cell fate by the Wnt signalling pathway , 1998, Nature.

[21]  B. Yankner,et al.  beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[23]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Mihm,et al.  Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. , 1999, The American journal of pathology.

[25]  Bruce A. Yankner,et al.  β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation , 1999 .

[26]  D. Rimm,et al.  Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.

[27]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[28]  D. Raible,et al.  Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. , 2000, Genes & development.

[29]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[30]  D. Raible,et al.  Environmental signals and cell fate specification in premigratory neural crest , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[32]  W. Pavan,et al.  Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Majumdar,et al.  Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. , 2000, Cancer research.

[34]  Kazuhiro Takahashi,et al.  Induction of Melanocyte-specific Microphthalmia-associated Transcription Factor by Wnt-3a* , 2000, The Journal of Biological Chemistry.

[35]  C. Goding,et al.  Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. , 2000, Genes & development.

[36]  A. Folpe,et al.  Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. , 2001, Advances in anatomic pathology.

[37]  K. Franssila,et al.  Microphthalmia Transcription Factor in the Immunohistochemical Diagnosis of Metastatic Melanoma: Comparison With Four Other Melanoma Markers , 2001, The American journal of surgical pathology.

[38]  E. Ziff,et al.  Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf , 2001, Mechanisms of Development.

[39]  E. Price,et al.  Sensorineural Deafness and Pigmentation Genes Melanocytes and the Mitf Transcriptional Network , 2001, Neuron.

[40]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[41]  A. McMahon,et al.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. , 2001, Development.

[42]  D. Fisher,et al.  Microphthalmia transcription factor , 2001, Cancer.

[43]  S. Takada,et al.  Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. , 2001, Developmental biology.

[44]  Sridhar Ramaswamy,et al.  Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability , 2002, Cell.